Literature DB >> 30069244

Fast Progressing His-Purkinje Conduction Disturbances in a Myotonic Dystrophy Pacient.

Radu Nicolae Ciudin1, Nic Claudiu Dragatoiu1, Sergiu Sipos1, Dan Nicolae Tesloianu2, Andreea Maria Ursaru2, Radu Brezeanu3, Ioan Mircea Coman4.   

Abstract

Myotonic dystrophy leads to multiple systemic complications and the age of death is earlier in myotonic dystrophy patients than in the general population. These patients have a high frequency of sudden death related to respiratory failure, cardiac arrhythmias and in particular to cardiac conduction disturbances. Prophylactic pacemaker implantation should be considered in asymptomatic myotonic dystrophy patients, which in the early stages of disease present minor conduction disturbances in 12-leads ECG. Even if the rate of progression of conduction abnormalities is usually slow, fast progression has been often observed thus making the clinical course of individual patients rather unpredictable.

Entities:  

Year:  2018        PMID: 30069244      PMCID: PMC6060298          DOI: 10.26574/maedica.2018.13.2.152

Source DB:  PubMed          Journal:  Maedica (Buchar)        ISSN: 1841-9038


  6 in total

1.  2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA).

Authors:  Michele Brignole; Angelo Auricchio; Gonzalo Baron-Esquivias; Pierre Bordachar; Giuseppe Boriani; Ole-A Breithardt; John Cleland; Jean-Claude Deharo; Victoria Delgado; Perry M Elliott; Bulent Gorenek; Carsten W Israel; Christophe Leclercq; Cecilia Linde; Lluís Mont; Luigi Padeletti; Richard Sutton; Panos E Vardas; Jose Luis Zamorano; Stephan Achenbach; Helmut Baumgartner; Jeroen J Bax; Héctor Bueno; Veronica Dean; Christi Deaton; Cetin Erol; Robert Fagard; Roberto Ferrari; David Hasdai; Arno W Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Patrizio Lancellotti; Ales Linhart; Petros Nihoyannopoulos; Massimo F Piepoli; Piotr Ponikowski; Per Anton Sirnes; Juan Luis Tamargo; Michal Tendera; Adam Torbicki; William Wijns; Stephan Windecker; Paulus Kirchhof; Carina Blomstrom-Lundqvist; Luigi P Badano; Farid Aliyev; Dietmar Bänsch; Helmut Baumgartner; Walid Bsata; Peter Buser; Philippe Charron; Jean-Claude Daubert; Dan Dobreanu; Svein Faerestrand; David Hasdai; Arno W Hoes; Jean-Yves Le Heuzey; Hercules Mavrakis; Theresa McDonagh; Jose Luis Merino; Mostapha M Nawar; Jens Cosedis Nielsen; Burkert Pieske; Lidija Poposka; Frank Ruschitzka; Michal Tendera; Isabelle C Van Gelder; Carol M Wilson
Journal:  Eur Heart J       Date:  2013-06-24       Impact factor: 29.983

2.  2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Cynthia M Tracy; Andrew E Epstein; Dawood Darbar; John P Dimarco; Sandra B Dunbar; N A Mark Estes; T Bruce Ferguson; Stephen C Hammill; Pamela E Karasik; Mark S Link; Joseph E Marine; Mark H Schoenfeld; Amit J Shanker; Michael J Silka; Lynne Warner Stevenson; William G Stevenson; Paul D Varosy
Journal:  J Am Coll Cardiol       Date:  2012-09-10       Impact factor: 24.094

3.  Electrophysiological study with prophylactic pacing and survival in adults with myotonic dystrophy and conduction system disease.

Authors:  Karim Wahbi; Christophe Meune; Raphaël Porcher; Henri Marc Bécane; Arnaud Lazarus; Pascal Laforêt; Tanya Stojkovic; Anthony Béhin; Hélène Radvanyi-Hoffmann; Bruno Eymard; Denis Duboc
Journal:  JAMA       Date:  2012-03-28       Impact factor: 56.272

4.  Localization of the sites of conduction abnormalities in a mouse model of myotonic dystrophy.

Authors:  S Saba; B A Vanderbrink; B Luciano; M J Aronovitz; C I Berul; S Reddy; D Housman; M E Mendelsohn; N A Estes; P J Wang
Journal:  J Cardiovasc Electrophysiol       Date:  1999-09

5.  Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1.

Authors:  William J Groh; Miriam R Groh; Chandan Saha; John C Kincaid; Zachary Simmons; Emma Ciafaloni; Rahman Pourmand; Richard F Otten; Deepak Bhakta; Girish V Nair; Mohammad M Marashdeh; Douglas P Zipes; Robert M Pascuzzi
Journal:  N Engl J Med       Date:  2008-06-19       Impact factor: 91.245

6.  Correlation between cardiac involvement and CTG trinucleotide repeat length in myotonic dystrophy.

Authors:  P Melacini; C Villanova; E Menegazzo; G Novelli; G Danieli; G Rizzoli; G Fasoli; C Angelini; G Buja; M Miorelli
Journal:  J Am Coll Cardiol       Date:  1995-01       Impact factor: 24.094

  6 in total
  1 in total

1.  Outcome of Myotonic Dystrophy 1 Depends on Comprehensive Diagnostic and Therapeutic Management.

Authors:  Josef Finsterer; Radu Nicolae Ciudin; Nic Claudiu Dragatoiu; Sergiu Sipos; Dan Nicolae Tesloianu; Andreea Maria Ursaru; Ioan Mircea Coman
Journal:  Maedica (Bucur)       Date:  2020-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.